BeStock  
Stocks › Biotechnology › KURA

Kura Oncology KURA

US equityMarket cap rank #3454Biotechnology
$6.91 −$0.44 (-5.99%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.94 +0.43%
Open$7.13
Prev close$7.35
Day range$6.89 – $7.37
Volume1.75M
Market cap$634.88M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$22.84M+10.1% YoY
Operating profit-$74.66M+6.7% YoY
Net profit-$70.22M+5.3% YoY
Diluted EPS-$0.78+8.2% YoY
Free cash flow-$54.89M+34.0% YoY
Operating cash flow-$54.44M

Revenue, last 8 quarters

$53.9MDec '24$14.1MMar '25$15.3MJun '25$20.8MSep '25$17.3MDec '25$18.3MMar '26$20.9MJun '26$22.8MSep '26

Net profit, last 8 quarters

$-19.2MDec '24$-57.4MMar '25$-66.1MJun '25$-74.1MSep '25$-81.0MDec '25$-73.3MMar '26$-68.3MJun '26$-70.2MSep '26

Diluted EPS by quarter

-0.22Dec '24-0.66Mar '25-0.75Jun '25-0.85Sep '25-0.92Dec '25-0.83Mar '26-0.77Jun '26-0.78Sep '26

Free cash flow by quarter

$268.8MDec '24$-72.2MMar '25$-30.2MJun '25$-83.2MSep '25$115.0MDec '25$-86.0MMar '26$-63.2MJun '26$-54.9MSep '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$53.9MFY24$67.5MFY25

Profitability & balance sheet

Gross margin98.8%
Operating margin-394.3%
Net margin-369.3%
Return on equity-224.9%
Return on assets-48.2%
Return on invested capital-199.4%
Current ratio3.60
Liabilities / assets96.8%
Cash & investments$492.10M
Total debt$23.95M
Net cash (debt)$468.14M

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $22.84M $20.87M $18.27M $67.48M $17.34M
Total Operating Revenue $22.84M $20.87M $18.27M $67.48M $17.34M
Cost of Revenue $371,000.00 $243,000.00 $262,000.00 $57,000.00 $57,000.00
Gross Profit $22.47M $20.63M $18.00M $67.43M $17.28M
Operating Expense $97.13M $93.64M $96.82M $371.06M $103.55M
Selling and Admin Expenses $30.25M $31.75M $31.56M $119.98M $39.14M
-General & Admin Expense $30.25M $31.75M $31.56M $119.98M $39.14M
Research & Development $66.88M $61.89M $65.26M $251.07M $64.41M
Operating Profit -$74.66M -$73.01M -$78.82M -$303.63M -$86.27M
Net Non-Operating Interest Income (Expense) $4.44M $4.69M $5.49M $25.26M $5.34M
Non-Operating Interest Income $4.79M $5.03M $5.83M $26.77M $5.69M
Non-Operating Interest Expense $350,000.00 $345,000.00 $336,000.00 $1.51M $346,000.00
Earnings from Equity Interest -$30.59M – – – –
Special Income (Charges) $30.59M – – – –
-Gain on Sale Of Business $30.59M – – – –
Pretax Profit -$70.22M -$68.32M -$73.33M -$278.37M -$80.93M
Tax $0.00 $5,000.00 $8,000.00 $297,000.00 $71,000.00
Net Profit -$70.22M -$68.33M -$73.33M -$278.67M -$81.00M
Profit from Continuing Operations -$70.22M -$68.33M -$73.33M -$278.67M -$81.00M
Net Income to Parent Company -$70.22M -$68.33M -$73.33M -$278.67M -$81.00M
Net Income to Common Stockholders -$70.22M -$68.33M -$73.33M -$278.67M -$81.00M
Basic EPS -$0.78 -$0.77 -$0.83 -$3.18 -$0.92
Diluted EPS -$0.78 -$0.77 -$0.83 -$3.18 -$0.92

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $566.50M $587.79M $652.55M $738.36M $738.36M
Total Current Assets $534.70M $559.44M $623.78M $708.66M $708.66M
Cash and Cash Equivalents & Short-Term Investments $492.10M $519.03M $580.82M $667.24M $667.24M
-Cash and Cash Equivalents $57.94M $70.24M $39.08M $149.10M $149.10M
-Short Term Investments $434.16M $448.78M $541.74M $518.14M $518.14M
Receivables $14.49M $9.45M $9.35M $8.80M $8.80M
-Accounts Receivable $14.49M $9.45M $9.35M $8.80M $8.80M
Inventory $4.98M $2.49M $843,000.00 $413,000.00 $413,000.00
Other Current Assets $23.13M $28.48M $32.77M $32.21M $32.21M
Total Non-Current Assets $31.80M $28.35M $28.77M $29.70M $29.70M
Net PPE $14.37M $14.62M $14.78M $15.16M $15.16M
-Gross PPE $18.31M $18.23M $18.02M $18.06M $18.06M
-Accumulated Depreciation -$3.94M -$3.61M -$3.24M -$2.90M -$2.90M
Other Non-Current Assets $17.43M $13.73M $13.99M $14.54M $14.54M
Total Liabilities $548.54M $539.36M $544.67M $564.23M $564.23M
Total Current Liabilities $148.73M $118.19M $101.50M $116.97M $116.97M
Payables $8.13M $2.45M $7.28M $5.26M $5.26M
-Accounts Payable $8.13M $2.39M $7.04M $5.02M $5.02M
Current Accrued Expenses $48.29M $40.41M $34.76M $39.09M $39.09M
Short-Term Debt and Capital Lease Obligation $10.41M $5.51M $1.28M $1.28M $1.28M
-Current Debt $8.53M $4.22M – – –
-Current Capital Lease Obligation $1.88M $1.29M $1.28M $1.28M $1.28M
Current Deferred Liabilities $63.49M $55.48M $47.70M $48.98M $48.98M
Total Non-Current Liabilities $399.81M $421.17M $443.17M $447.25M $447.25M
Long Term Debt and Capital Lease Obligation $15.42M $18.95M $22.99M $19.18M $19.18M
-Long Term Debt $1.30M $5.57M $9.75M $9.71M $9.71M
-Long Term Capital Lease Obligation $14.12M $13.37M $13.24M $9.47M $9.47M
Non-Current Deferred Liabilities $380.40M $398.60M $416.75M $424.91M $424.91M
Other Non-Current Liabilities $3.98M $3.62M $3.44M $3.17M $3.17M
Total Equity $17.96M $48.43M $107.88M $174.14M $174.14M
Stockholders' Equity $17.96M $48.43M $107.88M $174.14M $174.14M
Capital Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
-Common Stock $9,000.00 $9,000.00 $9,000.00 $9,000.00 $9,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.41B $1.37B $1.36B $1.35B $1.35B
Retained Earnings -$1.39B -$1.32B -$1.25B -$1.17B -$1.17B
Gains/Losses Not Affecting Retained Earnings -$2.18M -$1.21M -$380,000.00 $1.02M $1.02M
-Total Tax Payable – $59,000.00 $239,000.00 $239,000.00 $239,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow -$54.44M -$62.55M -$85.85M -$64.06M $117.27M
Net cash flow from continuing operations -$54.44M -$62.55M -$85.85M -$64.06M $117.27M
Net Income from Continuing Operations -$70.22M -$68.33M -$73.33M -$278.67M -$81.00M
Depreciation & Depletion & Amortization $329,000.00 $369,000.00 $355,000.00 $1.03M $403,000.00
Other Non-Cash Items $117,000.00 $111,000.00 $106,000.00 $515,000.00 $103,000.00
Change in Working Capital $7.79M -$2.17M -$20.50M $184.44M $187.80M
-Change in Receivables -$5.04M -$98,000.00 -$544,000.00 -$6.74M $27.13M
-Change in Inventory -$2.50M -$1.64M -$430,000.00 -$413,000.00 -$413,000.00
-Change in Prepaid Assets $5.49M $4.34M -$562,000.00 -$15.95M $2.89M
-Change in Payables and Accrued Expense $17.87M $5.01M -$14.19M $17.15M $2.35M
-Change in Other Current Assets $536,000.00 $336,000.00 $689,000.00 -$6.36M -$558,000.00
-Change in Other Current Liabilities $1.62M $250,000.00 $3.98M $1.04M $112,000.00
-Change In Other Working Capital -$10.19M -$10.36M -$9.44M $195.72M $156.29M
Net cash flow from investing $9.60M $92.21M -$24.23M -$13.10M -$64.60M
Net Cash Flow from Continuing Investing Activities $9.60M $92.21M -$24.23M -$13.10M -$64.60M
Net PPE Purchase and Sale -$445,000.00 -$656,000.00 -$128,000.00 -$6.64M -$2.32M
Net Investment Purchase and Sale $10.04M $92.87M -$24.10M -$6.46M -$62.28M
Financing Cash Flow $32.54M $1.50M $69,000.00 $1.79M $1.14M
Net Cash Flow from Continuing Financing Activities $32.54M $1.50M $69,000.00 $1.79M $1.14M
Proceeds from Stock Option Exercised $1.01M $1.50M $69,000.00 $1.79M $1.14M
Ending Cash Balance $57.94M $70.24M $39.08M $149.10M $149.10M
Net Change in Cash -$12.31M $31.16M -$110.02M -$75.36M $53.81M
Beginning Cash Balance $70.24M $39.08M $149.10M $224.46M $95.29M
Free Cash Flow -$54.89M -$63.21M -$85.98M -$70.70M $114.95M
Net Common Stock Issuance – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on KURA.

Sign in to join the discussion.

Scroll to Top